Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Condition(s):Sickle Cell DiseaseLast Updated:July 27, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Sickle Cell DiseaseLast Updated:July 27, 2023Recruiting
Condition(s):Sickle Cell DiseaseLast Updated:November 7, 2022Completed
Condition(s):Sickle Cell Disease; DrepanocytosisLast Updated:March 24, 2022Recruiting
Condition(s):Sickle Cell Disease; COVID-19Last Updated:March 2, 2023Active, not recruiting
Condition(s):Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)Last Updated:March 26, 2019Completed
Condition(s):Sickle Cell DiseaseLast Updated:July 26, 2016Completed
Condition(s):Sickle Cell DiseaseLast Updated:May 26, 2021Completed
Condition(s):Sickle Cell DiseaseLast Updated:January 10, 2019Completed
Condition(s):Sickle Cell Anemia; Pulmonary HypertensionLast Updated:February 4, 2013Completed
Condition(s):Vitamin D Deficiency; Sickle Cell DiseaseLast Updated:July 20, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.